Mark A. Feitelson

8.8k citations
139 papers · 6.6k · 3 hit papers · h-index 42

Impact in

  • Hepatology top 0.2%
    • Hepatitis C virus research
    • Hepatocellular Carcinoma Treatment and Prognosis
  • Epidemiology top 0.5%
    • Hepatitis B Virus Studies
    • Liver Disease Diagnosis and Treatment

Papers in

    • Hepatitis B Virus Studies 93
    • Liver Disease Diagnosis and Treatment 38
    • Hepatitis C virus research 55
    • Hepatitis Viruses Studies and Epidemiology 8

Mark A. Feitelson

139 papers receiving 6.4k citations

Mark A. Feitelson's Hit Papers

Human Viral Oncogenesis: A Cancer Hallmarks Analysis 2014 · 504 citations
5040+10+21Years since publication200400600

Peers

Mark A. Feitelson
Comparison fields: 5 of 120
  • Hepatology 2.1k
  • Epidemiology 3.5k
  • Cancer Research 1.0k
  • Oncology 1.4k
  • Molecular Biology 2.4k
Replace Robert Steele with:
Robert Steele United States
Yosef Shaul Israel
Hiroyuki Marusawa Japan
Jing‐hsiung James Ou United States
Bruno Sáinz Spain
Shiou‐Hwei Yeh Taiwan
Shiu‐Wan Chan United Kingdom
Katsuro Koike Japan
D W McCourt United States
Michael J. Brunda United States
Mark A. Feitelson relative to Robert Steele United States Robert Steele's profile →
Citations per field
00.5×1.5×2.2×
Robert Steele · 1×
Citations per year

Countries citing papers authored by Mark A. Feitelson

Since Specialization
Citations

This map shows the geographic impact of Mark A. Feitelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Feitelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Feitelson more than expected).

Fields of papers citing papers by Mark A. Feitelson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Feitelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Feitelson. The network helps show where Mark A. Feitelson may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark A. Feitelson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark A. Feitelson Line = papers co-authored together Mark A. Feitelson links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 139 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma
Hit paper breakdown →
2013669
2
Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3.
Hit paper breakdown →
1994599
3
Human Viral Oncogenesis: A Cancer Hallmarks Analysis
Hit paper breakdown →
2014504
4 1995323
5 2002279
6 1990212
7
Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma.
1997204
8 2006194
9 2013123
10
Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer.
1991113
11 2013101
12 1991101
13 2011100
14 2011100
15 200597
16 199992
17 200188
18 201284
19 202379
20 199871

About Mark A. Feitelson

Mark A. Feitelson is a scholar working on Epidemiology, Hepatology, Molecular Biology, Cancer Research and Oncology, having authored 139 papers that have together received 6.6k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (93 papers), Hepatitis C virus research (55 papers), Liver Disease Diagnosis and Treatment (38 papers), Cancer-related Molecular Pathways (12 papers), NF-κB Signaling Pathways (12 papers), Animal Virus Infections Studies (10 papers), Hepatitis Viruses Studies and Epidemiology (8 papers) and Ubiquitin and proteasome pathways (7 papers). The work is most often cited by research in Hepatology (2.1k citations), Epidemiology (3.5k citations), Cancer Research (1.0k citations), Oncology (1.4k citations) and Molecular Biology (2.4k citations). Mark A. Feitelson has collaborated with scholars based in United States, China and South Africa. Frequent co-authors include Alla Arzumanyan, Helena Reis, Zhaorui Lian, Enrique A. Mesri, Karl Münger, Jingbo Pan, Bill Sun, Marcia M. Clayton, Lifeng Duan and Xin Wei Wang. Their work appears in journals such as Hepatology, Journal of Virology, Oncogene, Cancer Research and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact